Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1990 Jun;64(6):2833–2840. doi: 10.1128/jvi.64.6.2833-2840.1990

Inhibition of human immunodeficiency virus (HIV) infection in vitro by anticarbohydrate monoclonal antibodies: peripheral glycosylation of HIV envelope glycoprotein gp120 may be a target for virus neutralization.

J E Hansen 1, H Clausen 1, C Nielsen 1, L S Teglbjaerg 1, L L Hansen 1, C M Nielsen 1, E Dabelsteen 1, L Mathiesen 1, S I Hakomori 1, J O Nielsen 1
PMCID: PMC249465  PMID: 1692349

Abstract

Carbohydrate structures are often involved in the initial adhesion of pathogens to target cells. In the present study, a panel of anticarbohydrate monoclonal antibodies (MAbs) was tested for their ability to inhibit in vitro human immunodeficiency virus infectivity. MAbs against three different N- and O-linked carbohydrate epitopes (LeY, A1, and sialyl-Tn) were able to block infection by cell-free virus as well as inhibit syncytium formation. Inhibition of virus infectivity was independent of virus strain (HTLVIIIB or patient isolate SSI-002), the cell line used for virus propagation (H9 or MT4), and the cell type used as the infection target (MT4, PMC, or selected T4 lymphocytes). Inhibition was observed when viruses were preincubated with MAbs but not when cells were preincubated with MAbs before inoculation, and the MAbs were shown to precipitate 125I-labeled gp120. The MAbs therefore define carbohydrate structures expressed by the viral envelope glycoprotein gp120, indicating that glycans of the viral envelope are possible targets for immunotherapy or vaccine development or both.

Full text

PDF
2833

Images in this article

2838Image
on p.2838
2838Image
on p.2838

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe K., Levery S. B., Hakomori S. The antibody specific to type 1 chain blood group A determinant. J Immunol. 1984 Apr;132(4):1951–1954. [PubMed] [Google Scholar]
  2. Abe K., McKibbin J. M., Hakomori S. The monoclonal antibody directed to difucosylated type 2 chain (Fuc alpha 1 leads to 2Gal beta 1 leads to 4[Fuc alpha 1 leads to 3]GlcNAc; Y Determinant). J Biol Chem. 1983 Oct 10;258(19):11793–11797. [PubMed] [Google Scholar]
  3. Adachi M., Hayami M., Kashiwagi N., Mizuta T., Ohta Y., Gill M. J., Matheson D. S., Tamaoki T., Shiozawa C., Hakomori S. Expression of Ley antigen in human immunodeficiency virus-infected human T cell lines and in peripheral lymphocytes of patients with acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC). J Exp Med. 1988 Feb 1;167(2):323–331. doi: 10.1084/jem.167.2.323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Allan J. S., Coligan J. E., Barin F., McLane M. F., Sodroski J. G., Rosen C. A., Haseltine W. A., Lee T. H., Essex M. Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. Science. 1985 May 31;228(4703):1091–1094. doi: 10.1126/science.2986290. [DOI] [PubMed] [Google Scholar]
  5. Andrews P. W., Gönczöl E., Fenderson B. A., Holmes E. H., O'Malley G., Hakomori S., Plotkin S. Human cytomegalovirus induces stage-specific embryonic antigen 1 in differentiating human teratocarcinoma cells and fibroblasts. J Exp Med. 1989 Apr 1;169(4):1347–1359. doi: 10.1084/jem.169.4.1347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bahraoui E., Clerget-Raslain B., Chapuis F., Olivier R., Parravicini C., Yagello M., Montagnier L., Gluckman J. C. A molecular mechanism of inhibition of HIV-1 binding to CD4+ cells by monoclonal antibodies to gp110. AIDS. 1988 Jun;2(3):165–169. [PubMed] [Google Scholar]
  7. Chanh T. C., Dreesman G. R., Kanda P., Linette G. P., Sparrow J. T., Ho D. D., Kennedy R. C. Induction of anti-HIV neutralizing antibodies by synthetic peptides. EMBO J. 1986 Nov;5(11):3065–3071. doi: 10.1002/j.1460-2075.1986.tb04607.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Clausen H., Hakomori S. ABH and related histo-blood group antigens; immunochemical differences in carrier isotypes and their distribution. Vox Sang. 1989;56(1):1–20. doi: 10.1111/j.1423-0410.1989.tb03040.x. [DOI] [PubMed] [Google Scholar]
  9. Clausen H., Levery S. B., Nudelman E., Tsuchiya S., Hakomori S. Repetitive A epitope (type 3 chain A) defined by blood group A1-specific monoclonal antibody TH-1: chemical basis of qualitative A1 and A2 distinction. Proc Natl Acad Sci U S A. 1985 Feb;82(4):1199–1203. doi: 10.1073/pnas.82.4.1199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Clausen H., Stroud M., Parker J., Springer G., Hakomori S. Monoclonal antibodies directed to the blood group A associated structure, galactosyl-A: specificity and relation to the Thomsen-Friedenreich antigen. Mol Immunol. 1988 Feb;25(2):199–204. doi: 10.1016/0161-5890(88)90068-5. [DOI] [PubMed] [Google Scholar]
  11. FOLEY G. E., LAZARUS H., FARBER S., UZMAN B. G., BOONE B. A., MCCARTHY R. E. CONTINUOUS CULTURE OF HUMAN LYMPHOBLASTS FROM PERIPHERAL BLOOD OF A CHILD WITH ACUTE LEUKEMIA. Cancer. 1965 Apr;18:522–529. doi: 10.1002/1097-0142(196504)18:4<522::aid-cncr2820180418>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  12. Fukushi Y., Nudelman E., Levery S. B., Hakomori S., Rauvala H. Novel fucolipids accumulating in human adenocarcinoma. III. A hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside (VI3NeuAcV3III3Fuc2nLc6). J Biol Chem. 1984 Aug 25;259(16):10511–10517. [PubMed] [Google Scholar]
  13. Gruters R. A., Neefjes J. J., Tersmette M., de Goede R. E., Tulp A., Huisman H. G., Miedema F., Ploegh H. L. Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase. Nature. 1987 Nov 5;330(6143):74–77. doi: 10.1038/330074a0. [DOI] [PubMed] [Google Scholar]
  14. Hakomori S. Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives. Cancer Res. 1985 Jun;45(6):2405–2414. [PubMed] [Google Scholar]
  15. Hansen J. E., Nielsen C. M., Nielsen C., Heegaard P., Mathiesen L. R., Nielsen J. O. Correlation between carbohydrate structures on the envelope glycoprotein gp120 of HIV-1 and HIV-2 and syncytium inhibition with lectins. AIDS. 1989 Oct;3(10):635–641. doi: 10.1097/00002030-198910000-00003. [DOI] [PubMed] [Google Scholar]
  16. Harada S., Koyanagi Y., Yamamoto N. Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science. 1985 Aug 9;229(4713):563–566. doi: 10.1126/science.2992081. [DOI] [PubMed] [Google Scholar]
  17. Hirohashi S., Clausen H., Yamada T., Shimosato Y., Hakomori S. Blood group A cross-reacting epitope defined by monoclonal antibodies NCC-LU-35 and -81 expressed in cancer of blood group O or B individuals: its identification as Tn antigen. Proc Natl Acad Sci U S A. 1985 Oct;82(20):7039–7043. doi: 10.1073/pnas.82.20.7039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kjeldsen T., Clausen H., Hirohashi S., Ogawa T., Iijima H., Hakomori S. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope. Cancer Res. 1988 Apr 15;48(8):2214–2220. [PubMed] [Google Scholar]
  19. Kozarsky K., Penman M., Basiripour L., Haseltine W., Sodroski J., Krieger M. Glycosylation and processing of the human immunodeficiency virus type 1 envelope protein. J Acquir Immune Defic Syndr. 1989;2(2):163–169. [PubMed] [Google Scholar]
  20. Kumarasamy R., Blough H. A. Galactose-rich glycoproteins are on the cell surface of herpes virus-infected cells. 1. Surface labeling and serial lectin binding studies of Asn-linked oligosaccharides of glycoprotein gC. Arch Biochem Biophys. 1985 Feb 1;236(2):593–602. doi: 10.1016/0003-9861(85)90663-0. [DOI] [PubMed] [Google Scholar]
  21. Lasky L. A., Groopman J. E., Fennie C. W., Benz P. M., Capon D. J., Dowbenko D. J., Nakamura G. R., Nunes W. M., Renz M. E., Berman P. W. Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein. Science. 1986 Jul 11;233(4760):209–212. doi: 10.1126/science.3014647. [DOI] [PubMed] [Google Scholar]
  22. Lasky L. A., Nakamura G., Smith D. H., Fennie C., Shimasaki C., Patzer E., Berman P., Gregory T., Capon D. J. Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell. 1987 Sep 11;50(6):975–985. doi: 10.1016/0092-8674(87)90524-1. [DOI] [PubMed] [Google Scholar]
  23. Lifson J., Coutré S., Huang E., Engleman E. Role of envelope glycoprotein carbohydrate in human immunodeficiency virus (HIV) infectivity and virus-induced cell fusion. J Exp Med. 1986 Dec 1;164(6):2101–2106. doi: 10.1084/jem.164.6.2101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Linsley P. S., Ledbetter J. A., Kinney-Thomas E., Hu S. L. Effects of anti-gp120 monoclonal antibodies on CD4 receptor binding by the env protein of human immunodeficiency virus type 1. J Virol. 1988 Oct;62(10):3695–3702. doi: 10.1128/jvi.62.10.3695-3702.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Matthews T. J., Weinhold K. J., Lyerly H. K., Langlois A. J., Wigzell H., Bolognesi D. P. Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5424–5428. doi: 10.1073/pnas.84.15.5424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Mizuochi T., Spellman M. W., Larkin M., Solomon J., Basa L. J., Feizi T. Structural characterization by chromatographic profiling of the oligosaccharides of human immunodeficiency virus (HIV) recombinant envelope glycoprotein gp120 produced in Chinese hamster ovary cells. Biomed Chromatogr. 1988 Nov;2(6):260–270. doi: 10.1002/bmc.1130020608. [DOI] [PubMed] [Google Scholar]
  27. Montefiori D. C., Robinson W. E., Jr, Mitchell W. M. Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A. 1988 Dec;85(23):9248–9252. doi: 10.1073/pnas.85.23.9248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Montelaro R. C., Robey W. G., West M. D., Issel C. J., Fischinger P. J. Characterization of the serological cross-reactivity between glycoproteins of the human immunodeficiency virus and equine infectious anaemia virus. J Gen Virol. 1988 Jul;69(Pt 7):1711–1717. doi: 10.1099/0022-1317-69-7-1711. [DOI] [PubMed] [Google Scholar]
  29. Nielsen C. M., Bygbjerg I. C., Vestergaard B. F. Detection of HIV antigens in eluates from whole blood collected on filterpaper. Lancet. 1987 Mar 7;1(8532):566–567. doi: 10.1016/s0140-6736(87)90213-3. [DOI] [PubMed] [Google Scholar]
  30. Nudelman E., Fukushi Y., Levery S. B., Higuchi T., Hakomori S. Novel fucolipids of human adenocarcinoma: disialosyl Lea antigen (III4FucIII6NeuAcIV3NeuAcLc4) of human colonic adenocarcinoma and the monoclonal antibody (FH7) defining this structure. J Biol Chem. 1986 Apr 25;261(12):5487–5495. [PubMed] [Google Scholar]
  31. Nuti M., Teramoto Y. A., Mariani-Costantini R., Hand P. H., Colcher D., Schlom J. A monoclonal antibody (B72.3) defines patterns of distribution of a novel tumor-associated antigen in human mammary carcinoma cell populations. Int J Cancer. 1982 May 15;29(5):539–545. doi: 10.1002/ijc.2910290509. [DOI] [PubMed] [Google Scholar]
  32. Olofsson S., Blomberg J., Lycke E. O-glycosidic carbohydrate-peptide linkages of Herpes simplex virus glycoproteins. Arch Virol. 1981;70(4):321–329. doi: 10.1007/BF01320247. [DOI] [PubMed] [Google Scholar]
  33. Ou C. Y., Kwok S., Mitchell S. W., Mack D. H., Sninsky J. J., Krebs J. W., Feorino P., Warfield D., Schochetman G. DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells. Science. 1988 Jan 15;239(4837):295–297. doi: 10.1126/science.3336784. [DOI] [PubMed] [Google Scholar]
  34. Park M. S., Oriol R., Nakata S., Terasaki P. I., Ford R., Bernoco D. ABH and Lewis antigens on lymphocytes: screening of pregnant women's sera with the B-cell cytotoxicity test. Transplant Proc. 1979 Dec;11(4):1947–1949. [PubMed] [Google Scholar]
  35. Pincus S. H., Wehrly K., Chesebro B. Treatment of HIV tissue culture infection with monoclonal antibody-ricin A chain conjugates. J Immunol. 1989 May 1;142(9):3070–3075. [PubMed] [Google Scholar]
  36. Popovic M., Sarngadharan M. G., Read E., Gallo R. C. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science. 1984 May 4;224(4648):497–500. doi: 10.1126/science.6200935. [DOI] [PubMed] [Google Scholar]
  37. Ray E. K., Blough H. A. The effect of herpesvirus infection and 2-deoxy-D-glucose on glycosphingolipids in BHK-21 cells. Virology. 1978 Jul 1;88(1):118–127. doi: 10.1016/0042-6822(78)90115-0. [DOI] [PubMed] [Google Scholar]
  38. Ruprecht R. M., Mullaney S., Andersen J., Bronson R. In vivo analysis of castanospermine, a candidate antiretroviral agent. J Acquir Immune Defic Syndr. 1989;2(2):149–157. [PubMed] [Google Scholar]
  39. Thomas E. K., Weber J. N., McClure J., Clapham P. R., Singhal M. C., Shriver M. K., Weiss R. A. Neutralizing monoclonal antibodies to the AIDS virus. AIDS. 1988 Feb;2(1):25–29. doi: 10.1097/00002030-198802000-00004. [DOI] [PubMed] [Google Scholar]
  40. Weber J. N., Clapham P. R., Weiss R. A., Parker D., Roberts C., Duncan J., Weller I., Carne C., Tedder R. S., Pinching A. J. Human immunodeficiency virus infection in two cohorts of homosexual men: neutralising sera and association of anti-gag antibody with prognosis. Lancet. 1987 Jan 17;1(8525):119–122. doi: 10.1016/s0140-6736(87)91964-7. [DOI] [PubMed] [Google Scholar]
  41. Weiss R. A., Clapham P. R., McClure M. O., McKeating J. A., McKnight A., Dalgleish A. G., Sattentau Q. J., Weber J. N. Human immunodeficiency viruses: neutralization and receptors. J Acquir Immune Defic Syndr. 1988;1(6):536–541. [PubMed] [Google Scholar]
  42. Wysocki L. J., Sato V. L. "Panning" for lymphocytes: a method for cell selection. Proc Natl Acad Sci U S A. 1978 Jun;75(6):2844–2848. doi: 10.1073/pnas.75.6.2844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Young W. W., Jr, Portoukalian J., Hakomori S. Two monoclonal anticarbohydrate antibodies directed to glycosphingolipids with a lacto-N-glycosyl type II chain. J Biol Chem. 1981 Nov 10;256(21):10967–10972. [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES